Our medical device company is developing spectacle lenses to slow the progression of myopia (nearsightedness) in children.
It is important to control the progression of myopia because:
Making their distance
vision blurry
Their myopia usually
worsens as they grow
Blindness can occur from
effects of myopia
Help study a technology
that may reduce the rate of
myopia progression.
SightGlass Vision Multicenter Trial to Study Novel Eyeglasses to Control Nearsightedness for FDA Approval
Click For Details
To deliver innovative, science-based treatments addressing the myopia pandemic to children around the world.
We love our patients and understand that less myopia improves lives.
We are science-based and embrace innovation. We try new things and understand that failure is part of the road to success.
When it counts, we measure twice and cut once. We believe in quality in all things and stake our reputation on it.
We question everything.
We believe in data.
We envision a world where children and their parents manage myopia. We imagine not what is, but what can be.
We believe in active collaboration. We are friendly and not afraid to be challenged. We are humans, after all.
3201 Ash Street Palo Alto, CA 94306 USA
© 2019 SightGlass Vision, Inc.
info@sightglassvision.com
3201 Ash Street Palo Alto, CA 94306 USA.
All rights reserved